Oct 31, 2026
A study showed that using polidocanol sclerotherapy significantly reduced nosebleeds in patients with HHT, with many feeling positive about the treatment.
Registered study, no results yet
Oct 27, 2026
This planned study aims to see if taking Pazopanib daily for 24 weeks can lessen the severity of nosebleeds in patients with HHT.